Clinical outcomes and immunotherapy retreatment in patients with metastatic NSCLC who complete at least two years of immune checkpoint blockade Meeting Abstract
| Authors: | Ricciuti, B.; Hong, L.; Gariazzo, E.; Gorria, T.; Thummalapalli, R.; Awosika, N.; Mollica, L.; Citarella, F.; Gandhi, M.; Elkrief, A.; Pecci, F.; Alessi, J.; Di Federico, A.; Makarem, M.; Saini, A.; Aldea, M.; Garbo, E.; Espinar, J. B.; Ferrara, R.; Alessio, C.; Pinato, D.; Schoenfeld, A.; Aboubakar Nana, F.; Mezquita, L.; Metro, G.; Vokes, N.; Awad, M. |
| Abstract Title: | Clinical outcomes and immunotherapy retreatment in patients with metastatic NSCLC who complete at least two years of immune checkpoint blockade |
| Meeting Title: | 2024 World Conference on Lung Cancer |
| Keywords: | biomarkers; long term survival; pd-(l)1 blockade |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2024 Sep 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S402 |
| Language: | English |
| ACCESSION: | WOS:001337925602235 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2024.09.730 |
| Notes: | Meeting Abstract: P4.11E.17 -- Source: Wos |
